1 study found for:    NCT01344187
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
Condition: Keratoconus
Interventions: Drug: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system;   Drug: Placebo: 0.0% riboflavin ophthalmic solution with the KXL system

Indicates status has not been verified in more than two years